Medicine and Dentistry
Malaria Falciparum
60%
Randomized Controlled Trial
60%
Adaptation
52%
Patient
48%
Primaquine
36%
Analysis
35%
Incidence
30%
COVID-19
30%
Antibiotic Resistance
30%
Person
30%
Clinical Trial
30%
Malaria
30%
Chloroquine
30%
Parasite (Microbiology)
25%
Laboratory
24%
Development
24%
Parasitemia
24%
Doctor of Philosophy
20%
Gene
20%
Therapeutic Procedure
19%
Arm
17%
Ear
16%
Infection
15%
Hybrid
15%
Remote Sensing
15%
Public Health
12%
Plasmodium Vivax Malaria
12%
Anemia
12%
Hemoglobinuria
12%
Adverse Event
12%
Antibiogram
10%
Division
9%
Student
9%
Cohort Effect
9%
Health
9%
Spleen
9%
Identity
9%
Host
9%
Gene Flow
9%
Evolution
9%
Superinfection
9%
Amino Acid Transporter
9%
Homozygosity
9%
Experience
7%
Low and Middle Income Countries
7%
Carbon
7%
Species
6%
Health Care Facility
6%
Health Care Cost
6%
Recurrent Infection
6%
Immunology and Microbiology
Plasmodium falciparum
100%
Plasmodium vivax
66%
Nasopharynx
35%
Plasmodium
30%
Antimicrobial Resistance
30%
Arm
30%
Chocolate Agar
30%
Bacitracin
15%
Glycocalyx
12%
Fever
8%
Beta-2 Microglobulin
6%
Genome-Wide Association Study
5%
Phylogenomics
5%
Biochemistry, Genetics and Molecular Biology
Genomics
66%
Parasite
45%
Transporter Genes
39%
Genome Variation
30%
Gene
24%
Duffy Binding Protein
15%
Reticulocyte
15%
Gene Frequency
15%
Genetic Marker
15%
Genotype
15%
Genetics
15%
Genotyping
6%
Single-Nucleotide Polymorphism
6%
Indel
6%